Association of β-lactam allergy labels with antibiotic use patterns, clinical outcomes and economic burden in China: a retrospective observational study
- 1Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, No. 38 Xueyuan Road, Haidian District, Beijing, 100191 China
- 2International Research Centre for Medicinal Administration, Peking University, Beijing, China
- 3Department of Medicine, School of Medicine, Yale University, New Haven, USA
Abstract
Background: β-lactam allergy labels (BALs) influence antibiotic prescribing decisions, prompting clinicians to opt for alternative antibiotics over β-lactams. However, evidence from China remains limited.
Methods: We conducted a multicenter retrospective cohort study using data from 7 hospitals in China between January 1 and June 30, 2021. Hospitalized patients who received systemic antibacterial therapy were included. The primary outcome was the pattern of antibiotic use. Secondary outcomes included hospital length of stay (LOS), in-hospital mortality and total hospitalization costs. Propensity score matching (PSM) was performed within each hospital to balance covariates between patients with and without a documented BAL. Hospital-specific associations were estimated using logistic or linear regression models and subsequently pooled through meta-analysis.
Results: Among 152,326 patients, 8,633 (5.7%) had a BAL. After PSM, 8,476 patients with and 32,767 without a BAL were analyzed. BALs were associated with lower use of β-lactam antibiotics (odds ratio [OR] 0.27, 95% confidence interval [CI] 0.20–0.37) and higher use of alternatives (OR 3.62, 95% CI 2.91–4.50). BALs were also associated with increased use of World Health Organization Access (OR 1.66, 95% CI 1.13–2.45) and Reserve (OR 1.66, 95% CI 1.19–2.32) antibiotics. No significant associations were observed with LOS or mortality, but BALs were associated with reduced hospitalization costs (MD -281.40 US dollars [USD], 95% CI -444.51 to -118.28 USD).
Conclusions: BALs were significantly associated with antibiotic prescribing patterns and lower hospitalization costs, but not with LOS or in-hospital mortality. Further research is warranted to explore these associations in specific populations.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12879-026-14192-8.
Related
- Association Between Diabetes Mellitus and CT-Measured Optic Nerve Sheath Diameter: A Retrospective Observational Study
- Association Between Texture-Modified Diet Intake Rate and Functional Outcomes After Acute Stroke: A Retrospective Observational Study
- Association Between Tumor Budding and Lymph Node Metastasis in Surgically Resected Colon Cancer: A Retrospective Observational Study
- Association Between Sleep-Related Medication Use and Recurrent Falls Among Inpatients: A Five-Year Retrospective Observational Study at a University Hospital
- Real-world device survival, revision burden and observed pain patterns after epidural spinal cord stimulation for neuropathic pain in adults with spinal cord injury: protocol for a longitudinal observational cohort study using routine clinical data
BibTeX
@article{wushouer2026association,
title = {{Association of β-lactam allergy labels with antibiotic use patterns, clinical outcomes and economic burden in China: a retrospective observational study}},
author = {Haishaerjiang Wushouer and Ruowei Xiao and Lin Hu and Fenqi Du and Weibin Li and Mengyuan Fu and Luwen Shi and Xiaodong Guan},
journal = {BMC Infectious Diseases},
year = {2026},
month = aug,
doi = {10.1186/s12879-026-14192-8},
url = {https://doi.org/10.1186/s12879-026-14192-8},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Association of β-lactam allergy labels with antibiotic use patterns, clinical outcomes and economic burden in China: a retrospective observational study
AU - Haishaerjiang Wushouer
AU - Ruowei Xiao
AU - Lin Hu
AU - Fenqi Du
AU - Weibin Li
AU - Mengyuan Fu
AU - Luwen Shi
AU - Xiaodong Guan
PY - 2026
DA - 2026/08/07
JO - BMC Infectious Diseases
DO - 10.1186/s12879-026-14192-8
UR - https://doi.org/10.1186/s12879-026-14192-8
AB - Background: β-lactam allergy labels (BALs) influence antibiotic prescribing decisions, prompting clinicians to opt for alternative antibiotics over β-lactams. However, evidence from China remains limited. Methods: We conducted a multicenter retrospective cohort study using data from 7 hospitals in China between January 1 and June 30, 2021. Hospitalized patients who received systemic antibacterial therapy were included. The primary outcome was the pattern of antibiotic use. Secondary outcomes included hospital length of stay (LOS), in-hospital mortality and total hospitalization costs. Propensity score matching (PSM) was performed within each hospital to balance covariates between patients with and without a documented BAL. Hospital-specific associations were estimated using logistic or linear regression models and subsequently pooled through meta-analysis. Results: Among 152,326 patients, 8,633 (5.7%) had a BAL. After PSM, 8,476 patients with and 32,767 without a BAL were analyzed. BALs were associated with lower use of β-lactam antibiotics (odds ratio [OR] 0.27, 95% confidence interval [CI] 0.20–0.37) and higher use of alternatives (OR 3.62, 95% CI 2.91–4.50). BALs were also associated with increased use of World Health Organization Access (OR 1.66, 95% CI 1.13–2.45) and Reserve (OR 1.66, 95% CI 1.19–2.32) antibiotics. No significant associations were observed with LOS or mortality, but BALs were associated with reduced hospitalization costs (MD -281.40 US dollars [USD], 95% CI -444.51 to -118.28 USD). Conclusions: BALs were significantly associated with antibiotic prescribing patterns and lower hospitalization costs, but not with LOS or in-hospital mortality. Further research is warranted to explore these associations in specific populations. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12879-026-14192-8.
SN - 1471-2334
ER -